Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2019 Jan 11;192:105283. doi: 10.1016/j.jsbmb.2019.01.001

Figure 9.

Figure 9.

Compound 1 (10 – 40 μM) inhibits PSA expression in LNCaP-AKR1C3 cells treated with either 100 nM 4-AD (AKR1C3 substrate) or by 1.0 nM by DHT (AR agonist). PSA expression, AR expression were measured by immunoblot analysis in cell lysates where β-tubulin was used as a loading control.